Earnings History Data for Denali Therapeutics Inc. (DNLI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Denali Therapeutics Inc.

Denali Therapeutics Inc. is a biotechnology company. It focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and others. Denali Therapeutics Inc. is based in SOUTH SAN FRANCISCO, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
27-02-2024 PM DNLI Denali Therapeutics Inc. 2,330 -0.86 -0.82 -0.75 Denali Therapeutics GAAP EPS of -$0.86
[2/27/2024 9:12 AM]		 23.39 6.50 
(38.48%)		 19.75 2.86 
(16.93%)		 15.45 - 33.31 4,344,767 1,440,000 42,594
07-11-2023 AH DNLI Denali Therapeutics 2,999 -0.72 -0.83 0.00 Denali Therapeutics GAAP EPS of -$0.72 beats by $0.09, revenue of $1.27M misses by $9.89M
[11/7/2023 5:20 PM]		 20.18 -1.05 
(-4.97%)		 21.64 0.41 
(1.93%)		 17.98 - 33.31 972,865 890,000 15,480
08-08-2023 AH DNLI Denali Therapeutics 3,784 1.30 -0.86 0.00 Denali Therapeutics EPS of $1.30, revenue of $294.12M beats by $254.61M
[8/8/2023 5:16 PM]		 24.77 -1.06 
(-4.10%)		 26.67 0.84 
(3.25%)		 21.74 - 39.43 1,076,042 480,000 1,229
08-05-2023 AH DNLI Denali Therapeutics 3,619 -0.80 -0.71 0.00 Denali Therapeutics GAAP EPS of -$0.80 misses by $0.10, revenue of $35.14M beats by $5.26M
[5/8/2023 5:13 PM]		 27.38 0.82 
(3.07%)		 26.56 0.0 
(0.00%)		 20.24 - 39.43 450,852 660,000 9,785
08-08-2022 AH DNLI Denali Therapeutics 4,106 -0.48 -0.52 0.00 Denali Therapeutics GAAP EPS of -$0.48 beats by $0.04, revenue of $52.48M beats by $7.82M
[8/8/2022 5:45 PM]		 37.27 0.02 
(0.05%)		 37.25 0.0 
(0.00%)		 20.24 - 56.80 694,411 620,000 24,882
05-05-2022 AH DNLI Denali Therapeutics 3,139 -0.53 -0.47 0.00 Denali Therapeutics GAAP EPS of -$0.53 misses by $0.03, revenue of $42.14M beats by $8.82M
[5/5/2022 5:45 PM]		 23.01 -0.96 
(-4.00%)		 23.97 0.0 
(0.00%)		 22.52 - 79.70 588,395 470,000 169
28-02-2022 AH DNLI Denali Therapeutics 4,020 -0.62 -0.41 0.00 Denali Therapeutics GAAP EPS of -$0.62 misses by $0.16, revenue of $12.51M misses by $32.31M
[2/28/2022 5:15 PM]		 32.10 -0.46 
(-1.41%)		 32.56 0.0 
(0.00%)		 30.25 - 79.70 515,302 480,000 77,545
04-08-2021 AH DNLI Denali Therapeutics Inc. 6,118 -0.50 -0.37 0.00 Denali Therapeutics EPS misses by $0.11, misses on revenue
[8/4/2021 5:03 PM]		 52.96 2.08 
(4.09%)		 50.88 0.0 
(0.00%)		 22.75 - 93.94 389,532 770,000 11,629
03-05-2021 PM DNLI Denali Therapeutics Inc. 7,431 -0.58 -0.37 0.00 Denali Therapeutics EPS misses by $0.21, misses on revenue
[5/3/2021 8:53 AM]		 58.33 -2.11 
(-3.49%)		 61.00 0.56 
(0.93%)		 21.41 - 93.94 422,413 440,000 2,487
25-02-2021 AH DNLI Denali Therapeutics Inc. 7,750 1.91 -0.55 -0.56 Denali Therapeutics EPS beats by $2.44, beats on revenue
[2/25/2021 5:44 PM]		 71.92 8.92 
(14.16%)		 64.85 1.85 
(2.94%)		 12.39 - 93.94 828,940 733,567 1,384